Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
NCT00797992Phase 4Completed
- Sponsor
- Instituto de Olhos de Goiânia
- Start
- Jan 2007
- Primary completion
- Nov 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in myopic choroidal neovascularization (mCNV), sponsored by Instituto de Olhos de Goiânia. Started Jan 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
myopic choroidal neovascularization (mCNV)
Beyond the preview
Go deeper on NCT00797992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797992.